This balance is disrupted by gain-of-function IFIH1 mutations or loss of ADAR activity, triggering spontaneous IFN production in immune disorders, including Aicardi-Goutières syndrome (AGS) and systemic lupus erythematosus (SLE) (20). Here, IFIH1 is linked to systemic lupus erythematosus.